Folic acid supplementation can adversely affect murine neural tube closure and embryonic survival

Human Molecular Genetics

Volumn 20, Issue 18, 2011, Pages 3678-3683

  Marean, Amber ^a   Graf, Amanda ^b   Zhang, Ying ^a   Niswander, Lee ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; GRAINYHEAD LIKE 2 PROTEIN; PROTEIN FREM2; PROTEIN LINE3P; PROTEIN SHROOM3; PROTEIN ZIC2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; GENE MUTATION; HETEROZYGOSITY; MISSENSE MUTATION; MOLECULAR PHYLOGENY; MOUSE; MOUSE EMBRYO; MOUSE MUTANT; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ANIMALS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; EMBRYONIC DEVELOPMENT; FEMALE; FOLIC ACID; HUMANS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NEURAL TUBE; NEURAL TUBE DEFECTS; PREGNANCY; SURVIVAL;

MURINAE;

EID: 80052232047     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr289     Document Type: Article

References (19)

1. Mitchell, L.E. (2005) Epidemiology of neural tube defects. Am. J. Med. Genet. C Semin. Med. Genet., 135C, 88-94.
2. Detrait, E.R., George, T.M., Etchevers, H.C., Gilbert, J.R., Vekemans, M. and Speer, M.C. (2005) Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol. Teratol., 27, 515-524.
3. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet, 338, 131-137.
4. De Wals, P., Tairou, F., Van Allen, M.I., Uh, S.H., Lowry, R.B., Sibbald, B., Evans, J.A., Van den Hof, M.C., Zimmer, P., Crowley, M. et al. (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med., 357, 135-142.
5. Houk, V.N., Oakley, G.P. Jr., Erickson, D., Mulinare, J. and James, L.M. (1992) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm. Rep., 41(RR-14), 1-7.
6. Harris, M.J. and Juriloff, D.M. (2010) An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res. A Clin. Mol. Teratol., 88, 653-669.
7. Harris, M.J. (2009) Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants. Birth Defects Res. A Clin. Mol. Teratol., 85, 331-339.
8. Zohn, I.E., Anderson, K.V. and Niswander, L. (2005) Using genomewide mutagenesis screens to identify the genes required for neural tube closure in the mouse. Birth Defects Res. A Clin. Mol. Teratol., 73, 583-590.
9. Gray, J.D., Nakouzi, G., Slowinska-Castaldo, B., Dazard, J.E., Rao, J.S., Nadeau, J.H. and Ross, M.E. (2010) Functional interactions between the LRP6 WNT co-receptor and folate supplementation. Hum. Mol. Genet., 19, 4560-4572.
10. Burren, K.A., Savery, D., Massa, V., Kok, R.M., Scott, J.M., Blom, H.J., Copp, A.J. and Greene, N.D. (2008) Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function. Hum. Mol. Genet., 17, 3675-3685.
11. Timmer, J.R., Mak, T.W., Manova, K., Anderson, K.V. and Niswander, L. (2005) Tissue morphogenesis and vascular stability require the Frem2 protein, product of the mouse myelencephalic blebs gene. Proc. Natl Acad. Sci. USA, 102, 11746-11750.
12. Pyrgaki, C., Liu, A. and Niswander, L. (2011) Grainyhead-like 2 regulates neural tube closure and adhesion molecule expression during neural fold fusion. Dev. Biol., 353, 38-49.
13. Yeung, L., Yang, Q. and Berry, R.J. (2008) Contributions of total daily intake of folic acid to serum folate concentrations. JAMA, 300, 2486-2487.
14. Li, C.C., Cropley, J.E., Cowley, M.J., Preiss, T., Martin, D.I. and Suter, C.M. (2011) A sustained dietary change increases epigenetic variation in isogenic mice. PLoS Genet., 7, e1001380.
15. Cordero, A., Mulinare, J., Berry, R.J., Boyle, C., Dietz, W., Johnston, R. Jr., Leighton, J. and Popovic, T. (2010) CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. Morb. Mortal Wkly Rep., 59, 980-984.
16. Nagai, T., Aruga, J., Minowa, O., Sugimoto, T., Ohno, Y., Noda, T. and Mikoshiba, K. (2000) Zic2 regulates the kinetics of neurulation. Proc. Natl Acad. Sci. USA, 97, 1618-1623.
17. Hildebrand, J.D. and Soriano, P. (1999) Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell, 99, 485-497.
18. Greene, N.D., Massa, V. and Copp, A.J. (2009) Understanding the causes and prevention of neural tube defects: insights from the splotch mouse model. Birth Defects Res. A Clin. Mol. Teratol., 85, 322-330.
19. Pani, L., Horal, M. and Loeken, M.R. (2002) Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev., 16, 676-680.